The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genome Editing-Global Market Insights and Sales Trends 2024
Synopsis
Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
The global Genome Editing market size is expected to reach US$ 6739.8 million by 2029, growing at a CAGR of 9.3% from 2023 to 2029. The market is mainly driven by the significant applications of Genome Editing in various end use industries. The expanding demands from the Cell Line Engineering, Animal Genetic Engineering and Plant Genetic Engineering,, are propelling Genome Editing market. CRISPR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the TALEN segment is estimated at % CAGR for the next seven-year period.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genome Editing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genome Editing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genome Editing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genome Editing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genome Editing covered in this report include Genscript, Horizon Discovery Group, Lonza, Merck KGaA, Sangamo Therapeutics and Thermo Fisher Scientific, etc.
The global Genome Editing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific
Global Genome Editing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genome Editing market, Segment by Type:
CRISPR
TALEN
ZFN
Global Genome Editing market, by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genome Editing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
The global Genome Editing market size is expected to reach US$ 6739.8 million by 2029, growing at a CAGR of 9.3% from 2023 to 2029. The market is mainly driven by the significant applications of Genome Editing in various end use industries. The expanding demands from the Cell Line Engineering, Animal Genetic Engineering and Plant Genetic Engineering,, are propelling Genome Editing market. CRISPR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the TALEN segment is estimated at % CAGR for the next seven-year period.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genome Editing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genome Editing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genome Editing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genome Editing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genome Editing covered in this report include Genscript, Horizon Discovery Group, Lonza, Merck KGaA, Sangamo Therapeutics and Thermo Fisher Scientific, etc.
The global Genome Editing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific
Global Genome Editing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genome Editing market, Segment by Type:
CRISPR
TALEN
ZFN
Global Genome Editing market, by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genome Editing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genome Editing
1.1 Genome Editing Market Overview
1.1.1 Genome Editing Product Scope
1.1.2 Genome Editing Market Status and Outlook
1.2 Global Genome Editing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genome Editing Market Size by Region (2018-2029)
1.4 Global Genome Editing Historic Market Size by Region (2018-2023)
1.5 Global Genome Editing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genome Editing Market Size (2018-2029)
1.6.1 North America Genome Editing Market Size (2018-2029)
1.6.2 Europe Genome Editing Market Size (2018-2029)
1.6.3 Asia-Pacific Genome Editing Market Size (2018-2029)
1.6.4 Latin America Genome Editing Market Size (2018-2029)
1.6.5 Middle East & Africa Genome Editing Market Size (2018-2029)
2 Genome Editing Market by Type
2.1 Introduction
2.1.1 CRISPR
2.1.2 TALEN
2.1.3 ZFN
2.2 Global Genome Editing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genome Editing Historic Market Size by Type (2018-2023)
2.2.2 Global Genome Editing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genome Editing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genome Editing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genome Editing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genome Editing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genome Editing Revenue Breakdown by Type (2018-2029)
3 Genome Editing Market Overview by Application
3.1 Introduction
3.1.1 Cell Line Engineering
3.1.2 Animal Genetic Engineering
3.1.3 Plant Genetic Engineering
3.2 Global Genome Editing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genome Editing Historic Market Size by Application (2018-2023)
3.2.2 Global Genome Editing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genome Editing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genome Editing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genome Editing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genome Editing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genome Editing Revenue Breakdown by Application (2018-2029)
4 Genome Editing Competition Analysis by Players
4.1 Global Genome Editing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genome Editing as of 2022)
4.3 Date of Key Players Enter into Genome Editing Market
4.4 Global Top Players Genome Editing Headquarters and Area Served
4.5 Key Players Genome Editing Product Solution and Service
4.6 Competitive Status
4.6.1 Genome Editing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Genscript
5.1.1 Genscript Profile
5.1.2 Genscript Main Business
5.1.3 Genscript Genome Editing Products, Services and Solutions
5.1.4 Genscript Genome Editing Revenue (US$ Million) & (2018-2023)
5.1.5 Genscript Recent Developments
5.2 Horizon Discovery Group
5.2.1 Horizon Discovery Group Profile
5.2.2 Horizon Discovery Group Main Business
5.2.3 Horizon Discovery Group Genome Editing Products, Services and Solutions
5.2.4 Horizon Discovery Group Genome Editing Revenue (US$ Million) & (2018-2023)
5.2.5 Horizon Discovery Group Recent Developments
5.3 Lonza
5.3.1 Lonza Profile
5.3.2 Lonza Main Business
5.3.3 Lonza Genome Editing Products, Services and Solutions
5.3.4 Lonza Genome Editing Revenue (US$ Million) & (2018-2023)
5.3.5 Merck KGaA Recent Developments
5.4 Merck KGaA
5.4.1 Merck KGaA Profile
5.4.2 Merck KGaA Main Business
5.4.3 Merck KGaA Genome Editing Products, Services and Solutions
5.4.4 Merck KGaA Genome Editing Revenue (US$ Million) & (2018-2023)
5.4.5 Merck KGaA Recent Developments
5.5 Sangamo Therapeutics
5.5.1 Sangamo Therapeutics Profile
5.5.2 Sangamo Therapeutics Main Business
5.5.3 Sangamo Therapeutics Genome Editing Products, Services and Solutions
5.5.4 Sangamo Therapeutics Genome Editing Revenue (US$ Million) & (2018-2023)
5.5.5 Sangamo Therapeutics Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Genome Editing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Genome Editing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Genome Editing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genome Editing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genome Editing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genome Editing Market Dynamics
11.1 Genome Editing Industry Trends
11.2 Genome Editing Market Drivers
11.3 Genome Editing Market Challenges
11.4 Genome Editing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
